Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SLIT One birch for seasonal birch pollen-induced rhinoconjunctivitis
2004-004924-11Phase 3Completed
- Sponsor
- ALK-Abelló
- Start
- Feb 2005
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in allergic rhinoconjunctivitis (ARC) and birch pollen allergy comparing SLIT One birch with Placebo (2 arms). Primary endpoints: Rhinoconjunctivitis symptom score and Rhinoconjunctivitis medication score. Started Feb 2005; status: completed.
02
Drugs
birch pollen extract
03
Conditions
allergic rhinoconjunctivitis (ARC)birch pollen allergy
Beyond the preview
Go deeper on 2004-004924-11.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2004-004924-11.